All compounds verified to pharmaceutical-grade purity standards.
BPC-157 is a synthetic peptide derived from a naturally occurring protein found in the stomach. Research has shown that BPC-157 may accelerate wound healing, support joint and tendon recovery, and reduce inflammation. It has demonstrated protective effects on the gut lining and potential neuroprotective properties. Commonly studied for its regenerative capabilities, this peptide is of growing interest in both soft tissue and musculoskeletal research.
CJC-1295 with Drug Affinity Complex (DAC) is a long-acting GHRH analog studied for its extended half-life and sustained growth hormone stimulation. CJC-1295 DAC binds to serum albumin, extending its activity window significantly. Research has investigated its role in growth hormone regulation, body composition, and metabolic support.
GHK-Cu (copper tripeptide-1) is a naturally occurring copper complex found in human plasma. Research has investigated its roles in collagen and elastin synthesis, wound healing signaling, anti-inflammatory activity, and cellular regeneration. It has been studied extensively in dermatological and tissue repair contexts.
Ipamorelin and CJC-1295 (No DAC) are synthetic peptides studied for their ability to stimulate growth hormone release through the ghrelin receptor and GHRH pathway. Research suggests this combination may support recovery, lean tissue preservation, metabolic function, and sleep-related growth hormone activity without significantly affecting cortisol or prolactin levels.
Melanotan II is a synthetic analog of the naturally occurring alpha-melanocyte-stimulating hormone. Research has studied its role in melanogenesis, appetite regulation, and energy homeostasis through activation of melanocortin receptors. It has been investigated in preclinical models for its effects on skin pigmentation and metabolic signaling pathways.
Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Research has focused on its effects on adipose tissue reduction, metabolic rate modulation, and appetite signaling pathways. Phase 2 clinical trials have demonstrated significant effects on body weight and metabolic markers.
Selank is a synthetic peptide modeled after the naturally occurring tuftsin molecule, recognized for its nootropic and anxiolytic properties. Research indicates that Selank may help regulate stress response, improve cognitive function, and support emotional balance by modulating serotonin and dopamine. Early studies suggest it may support improved focus, reduced anxiety, and enhanced mental clarity.
Semaglutide is a GLP-1 receptor agonist peptide studied for its effects on glucose regulation and appetite suppression. Preclinical and clinical research has investigated its role in metabolic function, body weight management, and glycemic control. It is one of the most widely researched peptides in metabolic and endocrine science.
TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4. Research has demonstrated its role in promoting cell migration, wound healing, and anti-inflammatory activity. Preclinical studies suggest TB-500 may support recovery from musculoskeletal injuries and promote tissue regeneration across multiple systems.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). Research has examined its role in stimulating endogenous growth hormone secretion, IGF-1 elevation, and visceral adipose tissue reduction. It is among the most extensively studied GHRH analogs, with a well-documented safety and efficacy profile in clinical literature.
Veridian Research